IQM debuts on Nasdaq at $1.9B, hedges on quantum's future

The line worth reading twice from IQM's Nasdaq debut is not the valuation. It is a sentence its own lawyers put in the prospectus: large-scale commercial traction of quantum computing technology may never occur. That is the company selling the stock telling you, in writing, that the thing it makes may never become a real market. According to TechCrunch, the Finnish quantum firm went public via a merger with the blank check company RAAQ at roughly a $1.9 billion valuation on July 2, 2026, making it Europe's first publicly traded quantum computer maker.

The market's reaction was measured. TechCrunch describes shares as failing to pop and spending most of the day below the IPO price, a lukewarm welcome for a listing that raised approximately €198 million (about $226 million) after costs and that lands only months after IQM closed a $300 million Series B last September. CEO and co-founder Jan Goetz framed it as validation regardless. "It always feels good to be first and to be a pioneer, but ultimately it's about long-term success," he told the outlet, adding that "it's a big success raising very shortly after the Series B."

Under the hood the business is small but growing. IQM had 22 customers as of 2025, up from 8 in 2024, spread across about 420 employees, roughly two-thirds in Espoo, Finland, with more than 100 in Munich. Goetz describes the go-to-market as selling machines into advanced supercomputing centers and data centers, plus cloud compute time on top. A recent deployment at Oak Ridge National Laboratory and a new quantum technology center in Maryland position the company to catch some of the US Department of Energy's push toward what it calls the world's first fault-tolerant, scientifically relevant quantum computer by 2028, a target President Trump's recent executive orders on quantum are meant to accelerate. Goetz's read, blunt: IQM can "benefit directly from it."

The honest caveat is that a growing customer count in a research-heavy market is not the same thing as commercial demand, and the prospectus itself says so. TechCrunch notes that no one, not even a company making quantum computers, can say when quantum chips will actually outperform classical ones across a useful range of tasks. What the reporting does not give you is the mix of paid commercial contracts versus government and academic grants inside those 22 customers, or where IQM stands on qubit count and error rates against the DOE's 2028 bar.

For the sector, the read is that public-market capital is now available to European quantum, but at prices that reflect scepticism rather than hype. The next test lands quickly: French rival Pasqal has announced a near-simultaneous SPAC plan, and how those shares trade will say whether the IQM debut was a company-specific reception or the ceiling for the whole cohort.